on Aug 22,2017
QUEBEC CITY, Aug. 22, 2017 - Feldan Therapeutics, Inc. today announced the issuance of its first patent covering the company's technology, the Feldan Shuttle platform. The United States Patent and …
Read Storyon Apr 30,2017
Feldan Therapeutics will be attending the BIO International Convention 2017 June 19-22, 2017 in San Diego, CA. We are excited to be part in this even again this year! Our …
Read Storyon Sep 30,2016
Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics Combined Feldan Shuttle and Elasmogen soloMER technology will be used to deliver intracellular candidates for two targets …
Read Story
2666, Boul. du Parc Technologique, Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com